Morgan Evans

Morgan is a dynamic leader in the field of bioanalysis and biological characterization, with over a decade of experience in both contract research organisations and academia. As the Head of Science and Scientific Innovation, Morgan spearheads the development and validation of pharmacokinetic, biomarker, and immunogenicity assays, utilizing state-of-the-art platforms such as MesoScale Discovery, Gyrolab, ELISA, Biacore, and Luminex. His leadership is characterized by a collaborative approach, fostering innovation through mentorship and partnerships with local universities. Morgan’s strategic vision and expert troubleshooting skills ensure the delivery of high-quality assays, precisely tailored to meet clients’ drug development needs. Committed to delivering the right science at the right time to improve patient lives, Morgan leads with a focus on scientific advancement and integrity, making a profound impact on the field and ultimately enhancing patient outcomes.